CDA Clinics partner with Bod Australia for patient-based observational study on Medical Cannabis
We partnered with one of our main Cannabidiol (CBD) producers, Bod, who provide quality pharmaceutical-grade medicine, in an exciting new patient-centred, observational study.
This study will monitor the ongoing health outcomes of patients taking Bod Pharmaceutical Medicinal Cannabis. The results will help Doctors to gain a better understanding of the role of Medicinal Cannabis therapies in treating many different health conditions and help shape further clinical trials.
If you are eligible for Medicinal Cannabis therapies and are interested in participating, please click here for more information.